Research programme: DNAJB1-PRKACA fusion protein degraders - Nurix
Latest Information Update: 28 Apr 2024
At a glance
- Originator Nurix
- Class Antineoplastics
- Mechanism of Action Proteolysis
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Research Solid tumours